SCHEMBL9109620

SCHEMBL9109620

O=C1Nc2cccnc2N[C@H]1c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.49
TNKS2 Q9H2K2 1/20 0.47
CYP1A2 P05177 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
KDM4E B2RXH2 2/20 0.41
MAPT P10636 2/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.39
IDH1 O75874 2/20 0.39
BRPF1 P55201 1/20 0.38
CREBBP Q92793 1/20 0.38
ALDH1A1 P00352 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.37
GFER P55789 1/20 0.37
HSD17B10 Q99714 1/20 0.37
NOS1 P29475 1/20 0.36
LMNA P02545 1/20 0.36
ADORA3 P0DMS8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9108518 1.00 GSK3B (0.49) GSK3BTNKS2CYP1A2SMN1; SMN2KDM4E
SCHEMBL9109613 1.00 GSK3B (0.49) GSK3BTNKS2CYP1A2SMN1; SMN2KDM4E
SCHEMBL2361451 0.78 KDM4E (0.57) TNKS2CYP1A2SMN1; SMN2KDM4EMAPT
SCHEMBL9109997 0.76 NOS1 (0.38) KDM4EMAPTKMT2AMEN1HTT
SCHEMBL14765037 0.76 GSK3B (0.76) GSK3BTNKS2CYP1A2SMN1; SMN2MAPT
SCHEMBL31477093 0.73 GSK3B (0.43) GSK3BTNKS2CYP1A2SMN1; SMN2KDM4E
SCHEMBL31477058 0.73 GSK3B (0.43) GSK3BTNKS2CYP1A2SMN1; SMN2KDM4E
SCHEMBL31477218 0.73 GSK3B (0.43) GSK3BTNKS2CYP1A2SMN1; SMN2KDM4E
SCHEMBL31477191 0.73 GSK3B (0.43) GSK3BTNKS2CYP1A2SMN1; SMN2KDM4E
SCHEMBL31477285 0.73 GSK3B (0.43) GSK3BTNKS2CYP1A2SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5424311-A A viricides for treating viral diseases; HIV enzyme inhibitor HOESCHST AKTIENGESELLSCHAFT (DE) 1995-06-13 US disclosed